Skip to main content

Continua Sponsors PAT & Real Time Quality Summit

Join us December 11-12 in Philadelphia!

Continua is a proud sponsor of the 3rd Annual PAT conference: Successfully Implement PAT Across the Drug Development Lifecycle to Increase Automation and Drive Cost Efficiency. This conference is designed exclusively for the Pharmaceutical and Biopharmaceutical community. Join 100+ leading PAT scientists, engineers, process development, CMC, MSAT and quality experts and discover interactive workshops addressing crucial challenges across regulatory requirements and implementing automation.

The maturity of PAT tools and the development of sophisticated software and chemometrics now provide the perfect opportunity to revolutionize traditional quality and analytical approaches, achieving the digital manufacturing maturity necessary for the future. With drug developers and manufacturers facing closer scrutiny on product quality than ever before, it’s time to make the most of evolving process analytical technology (PAT) to design robust and cost-effective control strategies to understand more about your biopharmaceutical products. 

Connect ground-breaking technologies with real-world manufacturing investment decisions to:

  • Explore cutting-edge data-driven case studies
  • Engage in dynamic roundtables
  • Deep dive into KOL-led panel debates
VIEW EVENT & REGISTER

MORE INSIGHTS & STORIES

The Next Step in Your Digital Strategy

Learn how to assess and build your DX strategy with a Digital Transformation Maturity Assessment.

The Ideal Architecture for Digital Transformation

Know the ‘current state’ and ‘future state’ of your business in real time with contextualized data from an enterprise-wide data hub.

The Business Case for Digital Transformation

Digital Transformation can unlock significant value across the entire supply chain and throughout the factory network.

Augmenting an MES

Bringing large amounts of data into your business systems requires the flexibility, security, and growth potential of a Unified Namespace ecosystem.

Integrating Lab Automation Systems

Learn how we integrated Nova FLEX cell culture analysis data with this pharma company’s plant control system to automate required actions.

Monitoring High-Value R&D Materials

This biotech company now monitors and tracks its R&D materials throughout the earliest stages of drug development using a UNS platform.

MES Data Informs Analytics

Explore several ways to extract MES data to support analytics: from hiring an MES engineer to querying the MES recipe, to creating a Unified Namespace.

Ideal Unified Namespace Pilots

Examples: Continuous Process Verification with batch-to-batch comparisons at different locations and Machine Learning with data from multiple systems.

MES Maintains Chain of Identity

This Cell/Gene Therapy customer’s autologous process required maintaining a strict chain of identity across the supply chain with no room for error.

MES Enables Predictability

By implementing an electronic batch record in MES, this customer practically eliminated errors—ultimately reducing finished goods inventory.